Bing Chen

1.1k total citations
44 papers, 773 citations indexed

About

Bing Chen is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bing Chen has authored 44 papers receiving a total of 773 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 9 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bing Chen's work include CAR-T cell therapy research (7 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Cancer Cells and Metastasis (4 papers). Bing Chen is often cited by papers focused on CAR-T cell therapy research (7 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Cancer Cells and Metastasis (4 papers). Bing Chen collaborates with scholars based in China, United States and Pakistan. Bing Chen's co-authors include Peipei Xu, Jian Ouyang, Ruju Wang, Yong Hu, Arsalan Ahmed, Huaqin Zuo, Changyu Wang, Pina M. Cardarelli, Alan J. Korman and Mark Selby and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Bing Chen

39 papers receiving 759 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bing Chen China 14 424 266 196 130 102 44 773
Michiel Kroesen Netherlands 12 464 1.1× 350 1.3× 559 2.9× 190 1.5× 120 1.2× 21 1.2k
Zhiyan Liu China 8 136 0.3× 332 1.2× 107 0.5× 87 0.7× 87 0.9× 30 799
Xian-Yang Li China 21 565 1.3× 358 1.3× 695 3.5× 78 0.6× 60 0.6× 37 1.3k
Dan G. Duda United States 5 200 0.5× 259 1.0× 151 0.8× 139 1.1× 55 0.5× 8 736
Zhongkai Gu China 6 292 0.7× 220 0.8× 172 0.9× 54 0.4× 102 1.0× 9 714
Hanxu Zhang China 9 113 0.3× 320 1.2× 124 0.6× 80 0.6× 68 0.7× 31 835
Benxia Zhang China 6 364 0.9× 184 0.7× 400 2.0× 86 0.7× 105 1.0× 10 696
Dennis Doleschel Germany 11 169 0.4× 148 0.6× 100 0.5× 257 2.0× 58 0.6× 17 678
Yazan S. Khaled United Kingdom 14 408 1.0× 207 0.8× 309 1.6× 65 0.5× 153 1.5× 33 829

Countries citing papers authored by Bing Chen

Since Specialization
Citations

This map shows the geographic impact of Bing Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Chen more than expected).

Fields of papers citing papers by Bing Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bing Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Chen. The network helps show where Bing Chen may publish in the future.

Co-authorship network of co-authors of Bing Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Bing Chen. A scholar is included among the top collaborators of Bing Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bing Chen. Bing Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Song, Xuming, et al.. (2024). The circRNA cEMSY Induces Immunogenic Cell Death and Boosts Immunotherapy Efficacy in Lung Adenocarcinoma. Cancer Research. 85(3). 497–514. 11 indexed citations
2.
3.
Li, Xuan, Bo Lan, Lei Zhou, et al.. (2024). Safety and Feasibility of Concurrent Abemaciclib and Postoperative Radiotherapy for Breast Cancer: A Real-World Analysis. International Journal of Radiation Oncology*Biology*Physics. 120(2). e342–e342.
4.
5.
Lan, Bo, Xuan Li, Lei Zhou, et al.. (2024). Safety of Concurrent Capecitabine and Radiotherapy in Breast Cancer Patients: A Real-World Analysis. International Journal of Radiation Oncology*Biology*Physics. 120(2). e345–e346. 1 indexed citations
6.
Yao, Bing, Qi‐Xiang Li, Bing Chen, et al.. (2024). NatD epigenetically activates FOXA2 expression to promote breast cancer progression by facilitating MMP14 expression. iScience. 27(2). 108840–108840. 8 indexed citations
7.
Huang, Xiaoquan, et al.. (2023). Global increase of colorectal cancer in young adults over the last 30 years: an analysis of the Global Burden of Disease Study 2019. Journal of Gastroenterology and Hepatology. 38(9). 1552–1558. 22 indexed citations
8.
Dong, Xiaorong, Fan Tong, Yunyi Kong, et al.. (2023). EP13.07-09 The Role of Radiotherapy in Extensive-Stage Small Cell Lung Cancer after Durvalumab-Based Immunochemotherapy: A Retrospective Study. Journal of Thoracic Oncology. 18(11). S710–S710.
9.
Xie, Mingchen, et al.. (2023). Systematic pan-cancer analysis identifies SLC35C1 as an immunological and prognostic biomarker. Scientific Reports. 13(1). 5331–5331. 4 indexed citations
10.
Sun, Ming, Peipei Xu, Enxiu Wang, et al.. (2021). Novel two-chain structure utilizing KIRS2/DAP12 domain improves the safety and efficacy of CAR-T cells in adults with r/r B-ALL. Molecular Therapy — Oncolytics. 23. 96–106. 24 indexed citations
11.
Chen, Siyuan, Hongyan Lai, Jingjing Zhao, et al.. (2021). The viral expression and immune status in human cancers and insights into novel biomarkers of immunotherapy. BMC Cancer. 21(1). 1183–1183. 8 indexed citations
12.
He, Aina, Yujing Huang, Weiwei He, et al.. (2020). Organoid culture system for patient-derived lung metastatic osteosarcoma. Medical Oncology. 37(11). 105–105. 30 indexed citations
13.
Chen, Bing, et al.. (2019). Application of mindfulness-based stress reduction in patients with non-small-cell lung cancer under chemotherapy. Zhonghua xiandai huli zazhi. 25(22). 2851–2854. 2 indexed citations
14.
Zhou, Di, Peipei Xu, Xiaoyan Shao, et al.. (2018). Pre-treatment red blood cell distribution width provides prognostic information in multiple myeloma. Clinica Chimica Acta. 481. 34–41. 23 indexed citations
15.
Xu, Peipei, Huaqin Zuo, Bing Chen, et al.. (2017). Doxorubicin-loaded platelets as a smart drug delivery system: An improved therapy for lymphoma. Scientific Reports. 7(1). 42632–42632. 143 indexed citations
16.
Zhou, Yi, Ruju Wang, Bing Chen, et al.. (2016). Daunorubicin and gambogic acid coloaded cysteamine-CdTe quantum dots minimizing the multidrug resistance of lymphoma in vitro and in vivo. International Journal of Nanomedicine. Volume 11. 5429–5442. 21 indexed citations
17.
Selby, Mark, John Engelhardt, Robert J. Johnston, et al.. (2016). Preclinical Development of Ipilimumab and Nivolumab Combination Immunotherapy: Mouse Tumor Models, In Vitro Functional Studies, and Cynomolgus Macaque Toxicology. PLoS ONE. 11(9). e0161779–e0161779. 175 indexed citations
18.
Gao, Hua, et al.. (2013). Anterior gradient 2: A new target to treat colorectal cancer. Medical Hypotheses. 80(6). 706–708. 8 indexed citations
19.
Korman, Alan J., Bing Chen, Changyu Wang, et al.. (2007). Activity of Anti-PD-1 in Murine Tumor Models: Role of “Host” PD-L1 and Synergistic Effect of Anti-PD-1 and Anti-CTLA-4 (48.37). The Journal of Immunology. 178(1_Supplement). S82–S82. 40 indexed citations
20.
Chen, Bing, Fangjun Liu, Lei Cui, et al.. (2002). [Tissue engineered tendon with skin fibroblasts as seed cells, a preliminary study].. PubMed. 82(16). 1105–7. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michiel Kroesen Breakdown of academic impact, for papers by Zhiyan Liu Breakdown of academic impact, for papers by Xian-Yang Li Breakdown of academic impact, for papers by Dan G. Duda Breakdown of academic impact, for papers by Zhongkai Gu Breakdown of academic impact, for papers by Hanxu Zhang Breakdown of academic impact, for papers by Benxia Zhang Breakdown of academic impact, for papers by Dennis Doleschel Breakdown of academic impact, for papers by Yazan S. Khaled
Rankless by CCL
2026